Carbamazepine vs Durvalumab

## Carbamazepine vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Carbamazepine** and **Durvalumab**.

## Mechanism of Action

**Carbamazepine**: Voltage-gated sodium channel blocker.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Carbamazepine — 25-65 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Carbamazepine — C15H12N2O; Durvalumab — N/A.

**Molecular Weight**: Carbamazepine — 236.2690 g/mol; Durvalumab — N/A.

**Type**: Carbamazepine — Small molecule; Durvalumab — Antibody.